Maniar, CA
Jatin Maniar, Sunnyvale, CA US
Patent application number | Description | Published |
---|---|---|
20090327102 | SYSTEM AND METHOD FOR PROVIDING REAL TIME ASSET VISIBILITY - A method and system for providing real time asset visibility for a plurality of assets and for providing a set of applications based on real time asset visibility, in particular, for the health care facility. The method includes the steps of collecting tag data from a plurality of active readers, identifying a particular asset coupled to the tag data and identifying the zone where the particular asset is located using an algorithm; and associating an asset state information, tag data, zone information, and other device information in the same environment of the asset for providing real time asset visibility. The invention activates an alerts frame work and sends action messages to the respective departments in the health care facility and also supports a set of applications including searching for availability of assets and location, data mining applications, dashboard applications, handheld applications, mapping applications, and reporting services. | 12-31-2009 |
Manaj Maniar, Freemont, CA US
Patent application number | Description | Published |
---|---|---|
20090192216 | Methods for the formulation and manufacture of artesunic acid for injection - A method for the manufacture of a sterile intravenous or intramuscular formulation of artesunic acid and the formulation are the subject of this invention. First the artesunic acid powder is sterilized with ethylene oxide and placed into a sterile container. The contained sterilized powder is then dissolved in sterile sodium phosphate buffered solution to produce an injectable intravenous or intramuscular formulation. The sodium phosphate dissolves and dilutes the artesunic acid powder without caking or frothing resulting in an improved drug product. The invention also relates to the formulation and a method of treating a patient with either uncomplicated or severe and complicated malaria. | 07-30-2009 |
20100184846 | Methods for the formulation and manufacture of artesunic acid for injection - A method for the manufacture of a sterile intravenous or intramuscular formulation of artesunic acid and the formulation are the subject of this invention. First the artesunic acid powder is sterilized with ethylene oxide and placed into a sterile container. The contained sterilized powder is then dissolved in sterile sodium phosphate buffered solution to produce an injectable intravenous or intramuscular formulation. The sodium phosphate dissolves and dilutes the artesunic acid powder without caking or frothing resulting in an improved drug product. The invention also relates to the formulation and a method of treating a patient with either uncomplicated or severe and complicated malaria. | 07-22-2010 |
Manjo Maniar, Freemont, CA US
Patent application number | Description | Published |
---|---|---|
20150313859 | METHODS AND COMPOSTIONS FOR TREATMENT OF CANCER - The invention discloses a method of treating cancer refractory to an anticancer agent comprising administering to a cancer patient a pharmaceutical composition comprising at least one compound of Formula 1 | 11-05-2015 |
Manoj Maniar, Fremont, CA US
Patent application number | Description | Published |
---|---|---|
20090036462 | Formulations for parenteral administration of (e)-2, 6-dialkoxystyryl 4-substituted benzylsulfones - Formulations are provided for parenteral administration of (amino substituted (e)-2,6-dialkoxystyryl 4-substituted benzylsulfones and the sodium and potassium salts thereof for the prevention and/or treatment of conditions mediated by abnormal cell proliferation. Composition for parenteral administration are provided which comprise an effective amount of compound of formula I | 02-05-2009 |
20090247624 | FORMULATIONS OF RADIOPROTECTIVE ALPHA BETA UNSATURATED ARYL SULFONES - Solution and suspension formulations are provided for administration prior to or after exposure to ionizing radiation for reducing toxic effects of the radiation in a subject which comprises an effective amount of at least one radioprotective α,β unsaturated aryl sulfone wherein the composition has a pH within the range of about 8 to about 9. | 10-01-2009 |
20100152096 | FORMULATIONS FOR PARENTERAL ADMINISTRATION OF AMINO-SUBSTITUTED (E)-2, 6-DIALKOXYSTYRYL 4-SUBSTITUTED BENZYLSULFONES - Formulations are provided for parenteral administration of (amino substituted (e)-2,6-dialkoxystyryl 4-substituted benzylsulfones and the sodium and potassium salts thereof for the prevention and/or treatment of conditions mediated by abnormal cell proliferation. | 06-17-2010 |
20110028504 | Formulation of radioprotective alpha beta unsaturated aryl sulfones - A pharmaceutical composition is provided for administration prior to or after exposure to ionizing radiation for reducing toxic effects of the radiation in a subject. An effective amount of the pharmaceutical composition provided comprising an effective amount of at least one radioprotective α, β unsaturated aryl sulfone, and at least one component selected from the group consisting of a) at least one water soluble polymer in an amount between about 0.5% and about 90% w/v, b) at least one chemically modified cyclodextrin in an amount between about 20% and about 60% w/v, and c) DMA in an amount between about 10% and about 50% w/v. | 02-03-2011 |
20120238624 | FORMULATIONS FOR THE TREATMENT OF PAIN - Formulations and methods are provided for the treatment of pain, and neuropathic pain in particular. The formulations are eutectic mixtures of a capsaicinoid and a local anesthetic agent and/or an anti-pruritic agent. | 09-20-2012 |
20130012589 | STABLE AQUEOUS FORMULATION OF (E)-4-CARBOXYSTYRYL-4-CHLOROBENZYL SULFONE - An aqueous pharmaceutical solution composition comprising between about 20 mg/ml to about 100 mg/ml of a radioprotective α,β-unsaturated aryl sulfone, a cosolvent comprising polyethylene glycol (PEG), polypropylene glycol, polyglycerol, DMA, propylene glycol, glycerol, ethanol, sorbitol, isopropyl alcohol, or a combination thereof in an amount between about 25% and about 90% w/v, and a water soluble Vitamin E derivative, wherein the composition has a pH within the range of about 7.0 to about 9.5. | 01-10-2013 |
20150238448 | FORMULATION OF RADIOPROTECTIVE ALPHA, BETA UNSATURATED ARYL SULFONES - Solution and suspension formulations are provided for administration prior to or after exposure to ionizing radiation for reducing toxic effects of the radiation in a subject which comprises an effective amount of at least one radioprotective α, β unsaturated aryl sulfone wherein the composition has a pH within the range of about 8 to about 9. | 08-27-2015 |
20150250745 | FORMULATION FOR THE TREATMENT OF PAIN - Formulations and methods are provided for the treatment of pain, and neuropathic pain in particular. The formulations are eutectic mixtures of a capsaicinoid and a local anesthetic agent and/or an anti-pruritic agent. | 09-10-2015 |
20150265549 | STABLE AQUEOUS FORMULATION OF (E)-4-CARBOXYSTYRYL-4-CHLOROBENZYL SULFONE - An aqueous pharmaceutical solution composition comprising between about 20 mg/ml to about 100 mg/ml of a radioprotective α,β-unsaturated aryl sulfone, a cosolvent comprising polyethylene glycol (PEG), polypropylene glycol, polyglycerol, DMA, propylene glycol, glycerol, ethanol, sorbitol, isopropyl alcohol, or a combination thereof in an amount between about 25% and about 90% w/v, and a water soluble Vitamin E derivative, wherein the composition has a pH within the range of about 7.0 to about 9.5. | 09-24-2015 |
20150313859 | METHODS AND COMPOSTIONS FOR TREATMENT OF CANCER - The invention discloses a method of treating cancer refractory to an anticancer agent comprising administering to a cancer patient a pharmaceutical composition comprising at least one compound of Formula 1 | 11-05-2015 |
Mihir Maniar, Sunnyvale, CA US
Patent application number | Description | Published |
---|---|---|
20100241568 | METHOD AND SYSTEM FOR TRANSFERRING SOFTWARE AND HARDWARE FEATURE LICENSES BETWEEN DEVICES - A method and system for transferring licenses between electronic devices supporting licensable features. Specifically, in a method a request is generated for transferring a license between first and second electronic devices. The request includes first information unique to the first electronic device, second information unique to the second electronic device. The request is sent to a license distributor to generates a master key. The master key includes a removal key including the first information and an add key including the second information. The removal key is used to remove the license from the first electronic device when the first information matches official versions of the first information. The add key is revealed from the master key when the license is successfully removed. The add key is used to add the license to the second electronic device when the second information matches official versions of the second information. | 09-23-2010 |
20140207909 | METHOD AND SYSTEM FOR TRANSFERRING SOFTWARE AND HARDWARE FEATURE LICENSES BETWEEN DEVICES - A method and system for transferring licenses between electronic devices supporting licensable features. Specifically, in a method a request is generated for transferring a license between first and second electronic devices. The request includes first information unique to the first electronic device, second information unique to the second electronic device. The request is sent to a license distributor to generates a master key. The master key includes a removal key including the first information and an add key including the second information. The removal key is used to remove the license from the first electronic device when the first information matches official versions of the first information. The add key is revealed from the master key when the license is successfully removed. The add key is used to add the license to the second electronic device when the second information matches official versions of the second information. | 07-24-2014 |
Mohammmed Y. Maniar, Saratoga, CA US
Patent application number | Description | Published |
---|---|---|
20100071055 | Two Parallel Engines for High Speed Transmit IPSEC Processing - The invention relates to a network interface system for interfacing a host system with a network. The network interface system includes a bus interface system, a media access control system, and a security system. The network interface offloads IPsec processing from the host processor. According to the invention, the security system includes two processors for encrypting and authenticating the outgoing data. Outgoing data packets are sent alternately to one or the other processor, whereby transmission processing can be accelerated relative to receive processing. | 03-18-2010 |